The German ADPKD Tolvaptan Treatment Registry is a Prospective, Observational, Multicentric Study of Patients Suffering From ADPKD That Are Considered for Tolvaptan Treatment.
Status: Recruiting
Location: See all (12) locations...
Study Type: Observational
SUMMARY
The German ADPKD Tolvaptan Treatment Registry is a prospective, observational, multicentric study of patients suffering from ADPKD that are considered for tolvaptan treatment. All ADPKD patients that are evaluated for treatment indication, or that are planned to be treated with tolvaptan, or that are already treated with tolvaptan are eligible. This registry is designed to provide real-world data on treatment management of patients with ADPKD.
Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Healthy Volunteers: f
View:
• Age \> 18 years
• ADPKD proven by positive family history and evidence of renal cysts or diagnosed by treating physician
• Presentation at our center for tolvaptan treatment indication, or tolvaptan treatment planned, or tolvaptan already started
Locations
Other Locations
Germany
Charité Universitätsmedizin Berlin
ACTIVE_NOT_RECRUITING
Berlin
University Hospital of Cologne
RECRUITING
Cologne
Medizinische Hochschule Hannover
RECRUITING
Hanover
University Hospital of Jena
RECRUITING
Jena
Praxisgemeinschaft Dr. Peschel
RECRUITING
Leipzig
University Hospital of Leipzig, Nephrologische Ambulanz
RECRUITING
Leipzig
Nierenzentrum Lübeck
RECRUITING
Lübeck
University Hospital of Schleswig-Holstein
RECRUITING
Lübeck
Fachinternistische Gemeinschaftspraxis Markgraeferland
RECRUITING
Müllheim
Nieren- und Diabeteszentrum Nettetal-Lobberich
ACTIVE_NOT_RECRUITING
Nettetal
Robert-Bosch-Krankenhaus
RECRUITING
Stuttgart
University Hospital of Wuerzburg, ZIM
RECRUITING
Würzburg
Contact Information
Primary
Roman-Ulrich Mueller, MD
roman-ulrich.mueller@uk-koeln.de
+49(0)22147897222
Backup
Cornelia Boehme
studienzentrum-medII@uk-koeln.de
+49(0)22147897222
Time Frame
Start Date: 2015-11
Estimated Completion Date: 2027-12
Participants
Target number of participants: 2000
Treatments
ADPKD
Patients with diagnosis of ADPKD, who are either evaluated for tolvaptan treatment indication, planned for tolvaptan treatment, or are already treated with tolvaptan
Authors
Claudia Witte
Related Therapeutic Areas
Sponsors
Leads: University of Cologne